Scott Davey Harriet Feilotter Funding supports study of breast cancer gene mutation

2010 Aug 10
Kingston, ON -- A team of Queen's University researchers has received $450,000 to study a gene mutation common to breast cancer patients. The three-year funding supports research aimed at developing an inexpensive diagnostic tool for identifying individuals with the gene mutation.

In the long term, we hope to identify people early who are at risk of developing breast cancer before they get cancer so they have the best possible surveillance and treatment options, says Scott Davey.

The Canadian Breast Cancer Foundation funding will continue a collaborative project between Dr. Davey and Dr. Harriet Feilotter, both members of the Department of Pathology and Molecular Medicine and the Cancer Research Institute.